CTSO - Cytosorbents Corp

QQQ $ 472.49 $ -2.05 (-0.43 %)

DIA $ 416.26 $ -1.07 (-0.26 %)

SPY $ 562.20 $ -1.67 (-0.3 %)

TLT $ 99.62 $ -1.25 (-1.24 %)

GLD $ 235.53 $ -1.83 (-0.77 %)

Previous Close

$ 1.42

Open

Bid

$ 1.41 x 100

Ask

-- x --

Day's Range

-- - --

52 Week Range

$ 0.70 - $ 2.15

Volume

379,913

Average Volume

Market Cap

77.29M

Beta (5Y Monthly)

$ 1.12

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-13-2024	06-30-2024	10-Q
2	05-09-2024	03-31-2024	10-Q
3	03-14-2024	12-31-2023	10-K
4	11-09-2023	09-30-2023	10-Q
5	08-01-2023	06-30-2023	10-Q
6	05-02-2023	03-31-2023	10-Q
7	03-09-2023	12-31-2022	10-K
8	11-03-2022	09-30-2022	10-Q
9	08-02-2022	06-30-2022	10-Q
10	05-03-2022	03-31-2022	10-Q
11	03-10-2022	12-31-2021	10-K
12	11-04-2021	09-30-2021	10-Q
13	08-03-2021	06-30-2021	10-Q
14	05-04-2021	03-31-2021	10-Q
15	03-09-2021	12-31-2020	10-K
16	11-04-2020	09-30-2020	10-Q
17	08-04-2020	06-30-2020	10-Q
18	05-05-2020	03-31-2020	10-Q
19	03-05-2020	12-31-2019	10-K
20	11-05-2019	09-30-2019	10-Q
21	08-06-2019	06-30-2019	10-Q
22	05-07-2019	03-31-2019	10-Q
23	03-07-2019	12-31-2018	10-K
24	11-06-2018	09-30-2018	10-Q
25	08-02-2018	06-30-2018	10-Q
26	05-08-2018	03-31-2018	10-Q
27	03-08-2018	12-31-2017	10-K
28	11-09-2017	09-30-2017	10-Q
29	08-07-2017	06-30-2017	10-Q
30	05-08-2017	03-31-2017	10-Q
31	03-03-2017	12-31-2016	10-K
32	11-07-2016	09-30-2016	10-Q
33	08-09-2016	06-30-2016	10-Q
34	05-09-2016	03-31-2016	10-Q
35	03-09-2016	12-31-2015	10-K
36	11-13-2015	09-30-2015	10-Q
37	08-13-2015	06-30-2015	10-Q
38	05-11-2015	03-31-2015	10-Q
39	03-31-2015	12-31-2014	10-K
40	11-12-2014	09-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

EF Hutton Maintains Buy on CytoSorbents, M...
08/14/2024 16:33:26

EF Hutton analyst Jason Kolbert maintains CytoSorbents (NASDAQ:CTSO) with a Buy and maintains $10 price target.

HC Wainwright & Co. Reiterates Neutral on ...
08/14/2024 12:00:03

HC Wainwright & Co. analyst Sean Lee reiterates CytoSorbents (NASDAQ:CTSO) with a Neutral and maintains $1 price target.

CytoSorbents Q2 2024 GAAP EPS $(0.08) Beat...
08/13/2024 20:42:54

CytoSorbents (NASDAQ:CTSO) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.10) ...

CytoSorbents Appoints Peter J. Mariani As ...
08/13/2024 20:25:52

Concurrently, Kathleen P. Bloch, CytoSorbents' current CFO, announced her retirement from the Company effective as of the c...

CytoSorbents Q2 2024 GAAP EPS $(0.08) Beat...
08/13/2024 20:13:38

CytoSorbents (NASDAQ:CTSO) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.10) ...

EF Hutton Initiates Coverage On CytoSorben...
07/29/2024 11:26:19

EF Hutton analyst Jason Kolbert initiates coverage on CytoSorbents (NASDAQ:CTSO) with a Buy rating and announces Price Targe...

why-cytosorbents-ctso-stock-is-trading-higher

Why CytoSorbents (CTSO) Stock Is Trading H...
07/02/2024 19:31:52

CytoSorbents shares are trading higher by 20% during Tuesday's session. The company entered into a new $20 million credit f...

CytoSorbents Entered Into A New $20M Credi...
07/02/2024 11:10:26

Proceeds from the facility are intended to provide non-dilutive working capital to support the Company's ongoing global Cyt...

Cytosorbents Announces The Regulatory Appr...
06/24/2024 11:19:11

The removal of the antithrombotic drugs Brilinta® (ticagrelor, AstraZeneca) and Xarelto® (rivaroxaban, Janssen/Bayer) during ca...

B. Riley Securities Reiterates Buy on Cyto...
05/15/2024 14:06:30

B. Riley Securities analyst Yuan Zhi reiterates CytoSorbents (NASDAQ:CTSO) with a Buy and maintains $3 price target.

CytoSorbents Q1 2024 GAAP EPS $(0.12), Inl...
05/09/2024 21:19:09

CytoSorbents (NASDAQ:CTSO) reported quarterly losses of $(0.12) per share which met the analyst consensus estimate. This is a 2...

HC Wainwright & Co. Reiterates Neutral on ...
05/07/2024 10:56:35

HC Wainwright & Co. analyst Sean Lee reiterates CytoSorbents (NASDAQ:CTSO) with a Neutral and maintains $1 price target.

HC Wainwright & Co. Reiterates Neutral on ...
03/15/2024 10:40:23

HC Wainwright & Co. analyst Sean Lee reiterates CytoSorbents (NASDAQ:CTSO) with a Neutral and maintains $1 price target.

Recap: CytoSorbents Q4 Earnings
03/14/2024 21:05:07

CytoSorbents Q4 2023 GAAP EPS $(0.12) Beat...
03/14/2024 21:00:37

CytoSorbents (NASDAQ:CTSO) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.14) ...

Earnings Scheduled For March 14, 2024
03/14/2024 09:52:13

Companies Reporting Before The Bell • Pharming (NASDAQ:PHAR) is projected to report earnings for its fourth quarter.

A Preview Of CytoSorbents's Earnings
03/13/2024 16:01:15

12-health-care-stocks-moving-in-wednesdays-pre-market-session

12 Health Care Stocks Moving In Wednesday'...
01/17/2024 13:05:58

CytoSorbents Reports Outcomes From A Rando...
01/17/2024 12:18:49

Better hemodynamic stability and lower rates of post-operative shock Patients in the CytoSorb group had lower median Vaso...

What To Know About HC Wainwright & Co.'s D...
12/29/2023 17:00:31